绝经后骨质疏松症的发生机制与治疗  

Mechanism and Treatment of Postmenopausal Osteoporosis

作　　者：朱兰[1] 潘晓鸥[1] 宋毅[1] 

机构地区：[1]四川大学华西医院药剂科,四川成都610041

出　　处：《中国药业》2005年第5期18-20,共3页China Pharmaceuticals

摘　　要：许多因素都可以影响骨代谢,雌激素与绝经后骨质疏松症的关系更为重要。目前性激素替代疗法(HRT)仍是绝经后骨质疏松症的主要治疗方法,但应全面、深刻地认识HRT的受益与风险。Many factors can impact bone metabolism,the relationship between estrin and postmenopausal is more important.At present, HRT is also the main treatment of postmenopausal,but we should fully understand the advantages and also the crisis of HRT.

关 键 词：绝经后骨质疏松症 性激素替代疗法 风险 

分 类 号：R363.21[医药卫生—病理学] R714.148[医药卫生—基础医学]